insulin glargine
UkraineDrugs containing this active substance
-
The drug is used for the treatment of diabetes mellitus in adults, adolescents, and children aged 2 years and older.
Form: solution for injection
Active substance Dosage insulin glargine 100 units/ml ATC: A10AE04
Manufacturer: Farmak JSC
-
The drug is intended for the treatment of diabetes mellitus in adults, adolescents, and children aged 2 years and older.
Form: solution for injection
Active substance Dosage insulin glargine 100 IU/ml ATC: A10AE04
Manufacturer: Sanofi-Aventis Deutschland GmbH
-
The drug is used to treat adults with type 2 diabetes to improve blood sugar control as an adjunct to diet, physical exercise, and metformin (or SGLT2 inhibitors).
Form: solution for injection
Active substance Dosage insulin glargine 100 units/ml lixisenatide 33 mcg/ml ATC: A10AE54
Manufacturer: Sanofi-Aventis Deutschland GmbH
-
The drug is used to treat adults with type 2 diabetes to improve blood sugar control as an adjunct to diet, physical exercise, and metformin (or SGLT2 inhibitors).
Form: solution for injection
Active substance Dosage insulin glargine 100 units/ml lixisenatide 50 mcg/ml ATC: A10AE54
Manufacturer: Sanofi-Aventis Deutschland GmbH
-
The drug is intended for the treatment of diabetes mellitus in adults, adolescents, and children aged 6 years and older.
Form: solution for injection
Active substance Dosage insulin glargine 300 IU/ml ATC: A10AE04
Manufacturer: Sanofi-Aventis Deutschland GmbH